Related Experiment Videos

[Use of antibiotics in the paediatric population]

Carlos Rodrigo1

  • 1Hospital Universitario Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, España. crodrigo.germanstrias@gencat.at

Enfermedades Infecciosas Y Microbiologia Clinica
|April 27, 2010
PubMed

Insights

This review details antibiotic classes and their pediatric use, offering recommendations for treating common childhood infections. It guides initial empirical antibiotic therapy based on causative agents in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Pharmacology
  • Antimicrobial Stewardship

Context:

  • Antibiotic resistance necessitates careful selection of antimicrobial agents.
  • Paediatric infections present unique pharmacokinetic and pharmacodynamic challenges.
  • Guidelines for paediatric antibiotic use require regular updates.

Purpose:

  • To review the characteristics and appropriate use of various antibiotic classes in children.
  • To provide evidence-based recommendations for empirical antibiotic therapy in paediatric infectious diseases.
  • To inform clinical practice regarding optimal antimicrobial selection for common childhood infections.

Summary:

  • This paper discusses the unique aspects of antibiotic administration in paediatric patients.
  • It provides a detailed review of major antibiotic groups, including beta-lactams, macrolides, and aminoglycosides.
  • Recommendations are proposed for empirical antibiotic therapy based on common paediatric pathogens.

Impact:

  • Facilitates informed decision-making for paediatric antibiotic prescribing.
  • Aims to improve treatment outcomes and minimize antimicrobial resistance in children.
  • Supports the development of updated clinical guidelines for paediatric infectious disease management.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
189
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
207
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
198
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
151
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
165
Antibiotic Selection00:57

Antibiotic Selection

Overview
59.2K